Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | 0.00% | +2.70% | -14.29% |
May. 13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
May. 09 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.29% | 35.64M | |
-41.58% | 2.95B | |
+19.36% | 1.88B | |
-1.05% | 1.63B | |
+33.96% | 1.34B | |
-16.83% | 959M | |
-21.96% | 888M | |
+7.07% | 842M | |
-26.29% | 623M | |
+10.85% | 513M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Transcript : Co-Diagnostics, Inc., Q2 2021 Earnings Call, Aug 12, 2021